Evolent Health, Inc (EVH) News

Evolent Health, Inc (EVH): $21.67

0.74 (-3.30%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add EVH to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#54 of 62

in industry

Filter EVH News Items

EVH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

EVH News Highlights

  • For EVH, its 30 day story count is now at 6.
  • Over the past 6 days, the trend for EVH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about EVH are ACT.

Latest EVH News From Around the Web

Below are the latest news stories about EVOLENT HEALTH INC that investors may wish to consider to help them evaluate EVH as an investment opportunity.

Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To Persist

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Yahoo | December 11, 2023

How Much Upside is Left in Evolent Health (EVH)? Wall Street Analysts Think 59.66%

The consensus price target hints at a 59.7% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | December 7, 2023

Insider Sell: CEO Seth Blackley Sells 141,000 Shares of Evolent Health Inc (EVH)

In a notable insider transaction, CEO Seth Blackley has sold 141,000 shares of Evolent Health Inc (NYSE:EVH) on December 5, 2023.

Yahoo | December 7, 2023

Evolent Health Looks to Start an Advance, But When?

Evolent Health, Inc. was rated a new market outperform (buy) at JMP Securities with a $37 price target. Evolent provides "an integrated administrative and clinical platform for health plan administration and population health management". In this daily bar chart of EVH, below, I can see that prices have made a choppy decline since April.

Yahoo | December 6, 2023

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced the pricing of $350.0 million aggregate principal amount of 3.50% convertible senior notes due 2029. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the

Yahoo | December 6, 2023

Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan

Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced that it intends to offer $350.0 million aggregate principal amount of convertible senior notes due 2029, subject to market and other conditions. Evolent also expects to grant the initial purchasers in the proposed offering an option to purchase up to an additional $52.5 mil

Yahoo | December 5, 2023

Best Momentum Stocks to Buy for November 20th

EVH, ACGL and AREC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 20, 2023.

Yahoo | November 20, 2023

Wall Street Analysts See a 56.84% Upside in Evolent Health (EVH): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 56.8% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | November 20, 2023

Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Welcome to the Evolent Earnings Conference Call for the quarter ended September 30th, 2023. As a reminder, this conference call is being recorded. Your hosts for the call today from Evolent are Seth Blackley, chief executive officer; and John Johnson, chief financial […]

Yahoo | November 5, 2023

Is There An Opportunity With Evolent Health, Inc.'s (NYSE:EVH) 49% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Evolent Health fair value estimate is US$53.12 Current share...

Yahoo | November 4, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!